Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Ardent Health, Inc. (ARDT) Financial Statements

Ardent Health, Inc. (ARDT) reported trailing twelve-month revenue of $6.4B (up 3.3% year on year) and net income of $78.2M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $304.8M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ARDTArdent Health, Inc.Follow ARDT — free
Medical Care Facilities · Healthcare
—
Price chart with a free account
Market cap
1.7B
P/E TTM
22.3
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Revenue5.415.976.326.41
Gross profit—0.500.430.39
Pre-tax income0.150.360.290.21
Income tax0.020.060.060.04
Net income0.050.210.140.08
Diluted EPS ($)0.431.580.960.55
Diluted shares (bn)0.1260.1330.141—

USD billions · SEC XBRL

Ardent Health, Inc. — questions

What is Ardent Health, Inc.'s revenue?
$6.4B over the twelve months to 2026-06-30, up 3.3% year on year, from its 10-Q and 10-K filings.
What is Ardent Health, Inc.'s net income?
$78.2M over the twelve months to 2026-06-30.
What is Ardent Health, Inc.'s free cash flow?
$304.8M over the twelve months to 2026-06-30.
What are Ardent Health, Inc.'s diluted earnings per share?
$0.55 over the twelve months to 2026-06-30.

Every figure on this page comes from Ardent Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.